Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

The pouches are used by less than 2% of US teens, the FDA said in granting the application allowing them to continue to be ...

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine ...

Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN ...

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...

Zyn is a pouch containing nicotine powder that is intended to rest in a user's mouth while the stimulant is absorbed into their bloodstream. The FDA's authorization of Zyn marks the first time ...

The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products ...

Nicotine pouch use grew in popularity during the survey period, as 24.7% of soldiers queried in 2023 reported using nicotine pouches compared with 20.2% in 2022.

Nicotine pouch use grew in popularity during the survey period, as 24.7% of soldiers queried in 2023 reported using nicotine pouches compared with 20.2% in 2022.

Active-duty U.S. Army soldiers are nearly 10 times more likely to use addictive nicotine pouches than are civilians, putting them at a higher risk for cancer after leaving the service, according to a ...